Vienna, Austria - Secondary end points from the recently published Carvedilol or Metoprolol European Trial (COMET) indicate that treatment with the beta blocker carvedilol in patients with heart ...

The largest clinical trial ever in chronic heart failure (HF) and the first head-to-head comparison of the effects of 2 beta-blockers on major outcomes has been reported by the investigators to show ...